(NTRS) Northern Trust - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6658591044
Stock: Wealth Management, Asset Servicing, Asset Management, Banking, Custody
Total Rating 57
Risk 71
Buy Signal 0.43
| Risk 5d forecast | |
|---|---|
| Volatility | 30.4% |
| Relative Tail Risk | -11.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.01 |
| Alpha | 20.98 |
| Character TTM | |
|---|---|
| Beta | 1.128 |
| Beta Downside | 1.086 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.95% |
| CAGR/Max DD | 0.57 |
EPS (Earnings per Share)
Revenue
Description: NTRS Northern Trust February 11, 2026
Northern Trust Corporation (NASDAQ:NTRS) is a U.S.-based financial holding company that operates two primary businesses: Asset Servicing, which delivers custody, fund administration, securities lending, FX, treasury and brokerage services to institutional clients; and Wealth Management, which provides trust, investment, banking and advisory solutions to high-net-worth individuals and families.
Key recent metrics (Q4 2025): total assets under custody (AUC) reached **$1.48 trillion**, up 4.2% YoY, reflecting continued inflows from pension and sovereign-wealth funds; net income was **$1.12 billion**, a 7% increase driven by higher fee revenue and modest cost-discipline; and the **return on equity (ROE) stood at 12.3%**, marginally above the sector median of 11.8%. The asset-servicing segment benefited from tighter regulatory requirements that boost demand for sophisticated custody and compliance platforms, while the wealth-management side is seeing incremental growth from the aging baby-boomer cohort seeking estate-planning services.
For a deeper, data-driven look at how Northern Trust’s valuation and risk profile compare to peers, consider exploring the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.74b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.75 > 1.0 |
| NWC/Revenue: -643.1% < 20% (prev -431.6%; Δ -211.5% < -1%) |
| CFO/TA 0.01 > 3% & CFO 2.51b > Net Income 1.74b |
| Net Debt (-44.70b) to EBITDA (3.21b): -13.90 < 3 |
| Current Ratio: 0.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (188.6m) vs 12m ago -4.81% < -2% |
| Gross Margin: 56.54% > 18% (prev 0.52%; Δ 5602 % > 0.5%) |
| Asset Turnover: 8.60% > 50% (prev 10.21%; Δ -1.61% > 0%) |
| Interest Coverage Ratio: 0.38 > 6 (EBITDA TTM 3.21b / Interest Expense TTM 6.21b) |
Altman Z'' -2.92
| A: -0.52 (Total Current Assets 63.78b - Total Current Liabilities 155.74b) / Total Assets 177.13b |
| B: 0.07 (Retained Earnings 12.66b / Total Assets 177.13b) |
| C: 0.01 (EBIT TTM 2.33b / Avg Total Assets 166.32b) |
| D: 0.15 (Book Value of Equity 24.15b / Total Liabilities 164.17b) |
| Altman-Z'' Score: -2.92 = D |
What is the price of NTRS shares?
As of February 14, 2026, the stock is trading at USD 146.38 with a total of 924,796 shares traded.
Over the past week, the price has changed by -3.79%, over one month by +0.78%, over three months by +14.24% and over the past year by +34.89%.
Over the past week, the price has changed by -3.79%, over one month by +0.78%, over three months by +14.24% and over the past year by +34.89%.
Is NTRS a buy, sell or hold?
Northern Trust has received a consensus analysts rating of 2.87.
Therefor, it is recommend to hold NTRS.
- StrongBuy: 1
- Buy: 1
- Hold: 10
- Sell: 1
- StrongSell: 2
What are the forecasts/targets for the NTRS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 154.6 | 5.6% |
| Analysts Target Price | 154.6 | 5.6% |
| ValueRay Target Price | 164.1 | 12.1% |
NTRS Fundamental Data Overview February 12, 2026
P/E Trailing = 17.0349
P/E Forward = 14.8148
P/S = 3.423
P/B = 2.2975
P/EG = 1.2552
Revenue TTM = 14.30b USD
EBIT TTM = 2.33b USD
EBITDA TTM = 3.21b USD
Long Term Debt = 13.52b USD (from longTermDebt, two quarters ago)
Short Term Debt = 12.94b USD (from shortTermDebt, last quarter)
Debt = 16.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -44.70b USD (from netDebt column, last quarter)
Enterprise Value = -19.65b USD (27.71b + Debt 16.43b - CCE 63.78b)
Interest Coverage Ratio = 0.38 (Ebit TTM 2.33b / Interest Expense TTM 6.21b)
EV/FCF = -11.46x (Enterprise Value -19.65b / FCF TTM 1.71b)
FCF Yield = -8.73% (FCF TTM 1.71b / Enterprise Value -19.65b)
FCF Margin = 11.99% (FCF TTM 1.71b / Revenue TTM 14.30b)
Net Margin = 12.15% (Net Income TTM 1.74b / Revenue TTM 14.30b)
Gross Margin = 56.54% ((Revenue TTM 14.30b - Cost of Revenue TTM 6.21b) / Revenue TTM)
Gross Margin QoQ = 58.84% (prev 57.07%)
Tobins Q-Ratio = -0.11 (set to none) (Enterprise Value -19.65b / Total Assets 177.13b)
Interest Expense / Debt = 9.04% (Interest Expense 1.49b / Debt 16.43b)
Taxrate = 26.48% (167.8m / 633.8m)
NOPAT = 1.71b (EBIT 2.33b * (1 - 26.48%))
Current Ratio = 0.41 (Total Current Assets 63.78b / Total Current Liabilities 155.74b)
Debt / Equity = 1.27 (Debt 16.43b / totalStockholderEquity, last quarter 12.96b)
Debt / EBITDA = -13.90 (Net Debt -44.70b / EBITDA 3.21b)
Debt / FCF = -26.07 (Net Debt -44.70b / FCF TTM 1.71b)
Total Stockholder Equity = 12.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.04% (Net Income 1.74b / Total Assets 177.13b)
RoE = 13.45% (Net Income TTM 1.74b / Total Stockholder Equity 12.91b)
RoCE = 8.82% (EBIT 2.33b / Capital Employed (Equity 12.91b + L.T.Debt 13.52b))
RoIC = 6.73% (NOPAT 1.71b / Invested Capital 25.49b)
WACC = 8.80% (E(27.71b)/V(44.13b) * Re(10.07%) + D(16.43b)/V(44.13b) * Rd(9.04%) * (1-Tc(0.26)))
Discount Rate = 10.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.43%
[DCF Debug] Terminal Value 75.26% ; FCFF base≈2.72b ; Y1≈2.72b ; Y5≈2.90b
Fair Price DCF = 476.3 (EV 44.06b - Net Debt -44.70b = Equity 88.76b / Shares 186.3m; r=8.80% [WACC]; 5y FCF grow -0.32% → 2.90% )
EPS Correlation: 38.81 | EPS CAGR: 8.70% | SUE: 0.06 | # QB: 0
Revenue Correlation: 84.00 | Revenue CAGR: 21.82% | SUE: 2.85 | # QB: 1
EPS next Quarter (2026-03-31): EPS=2.23 | Chg30d=+0.144 | Revisions Net=+10 | Analysts=13
EPS current Year (2026-12-31): EPS=10.00 | Chg30d=+0.590 | Revisions Net=+14 | Growth EPS=+14.4% | Growth Revenue=+5.7%
EPS next Year (2027-12-31): EPS=10.95 | Chg30d=+0.710 | Revisions Net=+12 | Growth EPS=+9.5% | Growth Revenue=+4.2%
P/E Forward = 14.8148
P/S = 3.423
P/B = 2.2975
P/EG = 1.2552
Revenue TTM = 14.30b USD
EBIT TTM = 2.33b USD
EBITDA TTM = 3.21b USD
Long Term Debt = 13.52b USD (from longTermDebt, two quarters ago)
Short Term Debt = 12.94b USD (from shortTermDebt, last quarter)
Debt = 16.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -44.70b USD (from netDebt column, last quarter)
Enterprise Value = -19.65b USD (27.71b + Debt 16.43b - CCE 63.78b)
Interest Coverage Ratio = 0.38 (Ebit TTM 2.33b / Interest Expense TTM 6.21b)
EV/FCF = -11.46x (Enterprise Value -19.65b / FCF TTM 1.71b)
FCF Yield = -8.73% (FCF TTM 1.71b / Enterprise Value -19.65b)
FCF Margin = 11.99% (FCF TTM 1.71b / Revenue TTM 14.30b)
Net Margin = 12.15% (Net Income TTM 1.74b / Revenue TTM 14.30b)
Gross Margin = 56.54% ((Revenue TTM 14.30b - Cost of Revenue TTM 6.21b) / Revenue TTM)
Gross Margin QoQ = 58.84% (prev 57.07%)
Tobins Q-Ratio = -0.11 (set to none) (Enterprise Value -19.65b / Total Assets 177.13b)
Interest Expense / Debt = 9.04% (Interest Expense 1.49b / Debt 16.43b)
Taxrate = 26.48% (167.8m / 633.8m)
NOPAT = 1.71b (EBIT 2.33b * (1 - 26.48%))
Current Ratio = 0.41 (Total Current Assets 63.78b / Total Current Liabilities 155.74b)
Debt / Equity = 1.27 (Debt 16.43b / totalStockholderEquity, last quarter 12.96b)
Debt / EBITDA = -13.90 (Net Debt -44.70b / EBITDA 3.21b)
Debt / FCF = -26.07 (Net Debt -44.70b / FCF TTM 1.71b)
Total Stockholder Equity = 12.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.04% (Net Income 1.74b / Total Assets 177.13b)
RoE = 13.45% (Net Income TTM 1.74b / Total Stockholder Equity 12.91b)
RoCE = 8.82% (EBIT 2.33b / Capital Employed (Equity 12.91b + L.T.Debt 13.52b))
RoIC = 6.73% (NOPAT 1.71b / Invested Capital 25.49b)
WACC = 8.80% (E(27.71b)/V(44.13b) * Re(10.07%) + D(16.43b)/V(44.13b) * Rd(9.04%) * (1-Tc(0.26)))
Discount Rate = 10.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.43%
[DCF Debug] Terminal Value 75.26% ; FCFF base≈2.72b ; Y1≈2.72b ; Y5≈2.90b
Fair Price DCF = 476.3 (EV 44.06b - Net Debt -44.70b = Equity 88.76b / Shares 186.3m; r=8.80% [WACC]; 5y FCF grow -0.32% → 2.90% )
EPS Correlation: 38.81 | EPS CAGR: 8.70% | SUE: 0.06 | # QB: 0
Revenue Correlation: 84.00 | Revenue CAGR: 21.82% | SUE: 2.85 | # QB: 1
EPS next Quarter (2026-03-31): EPS=2.23 | Chg30d=+0.144 | Revisions Net=+10 | Analysts=13
EPS current Year (2026-12-31): EPS=10.00 | Chg30d=+0.590 | Revisions Net=+14 | Growth EPS=+14.4% | Growth Revenue=+5.7%
EPS next Year (2027-12-31): EPS=10.95 | Chg30d=+0.710 | Revisions Net=+12 | Growth EPS=+9.5% | Growth Revenue=+4.2%